Radar Therapeutics Raises $13.4M in Seed Funding to Develop Smart Programmable Medicines Using Molecular RNA Sensors
May 23, 2024 05:00 AM Pacific Daylight Time BERKELEY, Calif.–(BUSINESS WIRE)–Radar Therapeutics, a biotech company developing smart programmable medicines, today announced the completion of an oversubscribed $13.4 million in seed financing led by NfX Bio….